Ask AI

Translating Discoveries to Clinical Practice to Advance the Care of Patients With Cutaneous Squamous Cell Carcinoma

Enhance your understanding of adjuvant immune checkpoint inhibitors for patients with high-risk cutaneous squamous cell carcinoma through evidence-based education aligned with current guidelines and clinical trial data. This certified curriculum, featuring an expert-authored Clinical Focus module, ClinicalThought commentary, engaging podcast, and downloadable slide resources, provides practical strategies to refine patient selection, manage immunotherapy-related toxicities, and deliver optimal, evidence-based care.

Share

Program Content

Activities

Immunotherapy in cSCC
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc